|
|
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results - CNNMoney.com (press release) |
|
CNNMoney.com (press release)Zerenex has recently completed a Phase 2 clinical program as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal ... |
|
|
The Case for Dual Renin-Angiotensin System Inhibition - Archives of Internal Medicine |
|
Archives of Internal MedicineKu et al 1 cite the findings of the Renal Outcomes With Telmisartan, Ramipril, or Both, in People at High Vascular Risk (ONTARGET) trial 2 in arguing ... |
|
Covidien Changes Optimark Label To Include Renal Risk - Update - RTT News |
|
RTT NewsThe FDA recommended the avoidance of GBCAs in patients with severe renal impairment, in 2007. "In addition, the FDA will hold a joint Advisory Committees ... |
|
Fresenius Medical to buy Health IT Services Group - ModernHealthcare.com |
|
ModernHealthcare.comFresenius, which operates a network of dialysis facilities, said it will use Health IT Services' nephrology-specific electronic health record to further ... |
|
Writer of "The Horse Whisperer" still awaits transplant - Horsetalk |
|
HorsetalkThe author of the book which has sold 15 million copies, and was made into a movie starring Robert Redford, requires 15 hours of dialysis each week. ... |
|
|
|
|
<< Start < Prev 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 Next > End >>
|
|
Page 1884 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
